Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Duek

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Oncotarget|September 11, 2016
The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivoGabriela Rozic, Lena Paukov, Jana Jakubikova, et al.
Blood|May 14, 2014
Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNsAdrian Duek, Pontus Lundberg, Takafumi Shimizu, et al.
Oncotarget|August 25, 2018
STK405759 as a combination therapy with bortezomib or dexamethasone, in <i>in vitro</i> and <i>in vivo</i> multiple myeloma modelsGabriela Rozic, Lena Paukov, Ziv Cohen, et al.
Blood|November 23, 2013
Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemiaJean Grisouard, Mario Ojeda-Uribe, Renate Looser, et al.
Annals of Hematology|June 11, 2024
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter studyAlon Rozental, Erez Halperin, Chiya Leibovitch, et al.
Genes, Chromosomes & Cancer|January 25, 2019
Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16)Adrian Duek, Luba Trakhtenbrot, Ninette Amariglio, et al.
Cancer Medicine|January 25, 2023
AL amyloidosis clonal plasma cells are regulated by microRNAs and dependent on anti-apoptotic BCL2 family membersHila Fishov, Eli Muchtar, Mali Salmon-Divon, et al.
European Journal of Haematology|September 26, 2021
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cellsOfrat Beyar-Katz, Nino Kikozashvili, Yael Bar On, et al.
Leukemia Research|September 15, 2015
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practiceMartin H Ellis, Noa Lavi, Elena Mishchenko, et al.
Genes, Chromosomes & Cancer|May 7, 2016
Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?Merav Leiba, Adrian Duek, Ninette Amariglio, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Oncotarget|September 11, 2016
The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivoGabriela Rozic, Lena Paukov, Jana Jakubikova, et al.
Blood|May 14, 2014
Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNsAdrian Duek, Pontus Lundberg, Takafumi Shimizu, et al.
Oncotarget|August 25, 2018
STK405759 as a combination therapy with bortezomib or dexamethasone, in <i>in vitro</i> and <i>in vivo</i> multiple myeloma modelsGabriela Rozic, Lena Paukov, Ziv Cohen, et al.
Blood|November 23, 2013
Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemiaJean Grisouard, Mario Ojeda-Uribe, Renate Looser, et al.
Annals of Hematology|June 11, 2024
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter studyAlon Rozental, Erez Halperin, Chiya Leibovitch, et al.
Genes, Chromosomes & Cancer|January 25, 2019
Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16)Adrian Duek, Luba Trakhtenbrot, Ninette Amariglio, et al.
Cancer Medicine|January 25, 2023
AL amyloidosis clonal plasma cells are regulated by microRNAs and dependent on anti-apoptotic BCL2 family membersHila Fishov, Eli Muchtar, Mali Salmon-Divon, et al.
European Journal of Haematology|September 26, 2021
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cellsOfrat Beyar-Katz, Nino Kikozashvili, Yael Bar On, et al.
Leukemia Research|September 15, 2015
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practiceMartin H Ellis, Noa Lavi, Elena Mishchenko, et al.
Genes, Chromosomes & Cancer|May 7, 2016
Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?Merav Leiba, Adrian Duek, Ninette Amariglio, et al.
Pageof 4